Wireless Assessment of Respiratory and Circulatory Distress in Vascular Surgical Patients - An Observational Study
WARD-VASC
Continuous Monitoring of Physiological Parameters for Early Detection of Complications in Postoperative Vascular Surgical Patients - An Observational Study
1 other identifier
observational
40
1 country
1
Brief Summary
Vascular postsurgical patients have a high risk of morbidity and mortality. On top of that, patients undergoing vascular surgery usually have a high burden of comorbidities. After a short stay in the post-operative ward, patients are usually transferred to a standard surgical ward. Monitoring of physiological parameters by intermittent manual recordings 8-12 hours apart, is today's standard of care in hospitals. However, no effect on length of hospital stay, morbidity or mortality has been proven. This may be due to the up to 12 hours of unobserved time that can occur, where physiological deviations can progress resulting in clinical adverse outcomes such as myocardial infarction or stroke. Vital sign micro events are occurrences when patient physiological parameters deviates significantly from what can be understood as normal physiology. Since adverse outcomes in patients rarely happens without deviating physiological parameters, it is to be investigated if micro events can be used to predict clinical adverse outcomes to patients. We acknowledge that during the observation period, the number of false alarms should be kept to a minimum to avoid the risk of 'alarm fatigue'
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2020
CompletedFirst Submitted
Initial submission to the registry
November 9, 2020
CompletedFirst Posted
Study publicly available on registry
November 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 23, 2021
CompletedApril 27, 2022
April 1, 2022
5 months
November 9, 2020
April 20, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Physiologic abnormal vital signs - Cumulative duration
Cumulative duration of physiologic vital signs within certain thresholds outside normalcy
From inclusion until 4 days or discharge
Secondary Outcomes (1)
Physiologic abnormal vital signs - Episodes of sustained duration
From inclusion until 4 days or discharge
Other Outcomes (4)
Any serious adverse events
30 days
Readmission
6 months
ICU admission
6 months
- +1 more other outcomes
Study Arms (1)
Primary group
Eligibility Criteria
40 patients admitted for elective or subacute vascular surgical intervention, as noted in the inclusion criteria, will be included on the day before their surgical procedure.
You may qualify if:
- Patients admitted to Copenhagen University Hospital
- Patients with Peripheral Arteriel Disease(PAD)
- Patients undergoing open infraligamentary revascularization
- Emergency or subacute surgery
- Admission the day before surgery, and expected length of stay more than 2 days.
You may not qualify if:
- Patient expected not to cooperate
- Patients with dementia or not able to give informed consent
- Patient allergic to plaster, plastic or silicone
- Patients with pacemaker or implantable cardioverter-defibrillator (ICD) unit
- Patients in isolation
- Active therapy withdrawn
- Patients previously included in the other study branches
- Patients with \>20 mmHg in difference in systolic blood pressure between the two arms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, 2100, Denmark
Biospecimen
Troponin-T
Study Officials
- STUDY DIRECTOR
Eske K Aasvang
Rigshospitalet, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. Med.
Study Record Dates
First Submitted
November 9, 2020
First Posted
November 16, 2020
Study Start
August 17, 2020
Primary Completion
January 23, 2021
Study Completion
July 23, 2021
Last Updated
April 27, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share